Wolfe Research analyst Timna Tanners downgrades Alcoa (NYSE:AA) from Outperform to Peer Perform.
Calithera Biosciences Q2 Sales $3.00M, Same YoY
Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.